We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$369M
AUM Growth
-$114M
Cap. Flow
-$97.1M
Cap. Flow %
-26.31%
Top 10 Hldgs %
18.38%
Holding
302
New
88
Increased
47
Reduced
69
Closed
95

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.93M
2
NVS icon
Novartis
NVS
+$6.11M
3
APTV icon
Aptiv
APTV
+$5.73M
4
BFH icon
Bread Financial
BFH
+$5.18M
5
NBR icon
Nabors Industries
NBR
+$4.96M

Sector Composition

Rank Sector Weight
1 Healthcare 31%
2 Technology 24.95%
3 Industrials 8.8%
4 Consumer Discretionary 8.28%
5 Communication Services 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSP icon
51
Insperity
NSP
$1.95B
$2.37M 0.64%
+91,500
New +$2.15M
GSK icon
52
GSK
GSK
$103B
$2.35M 0.64%
46,264
-64,216
-58% -$3.2M
COR
53
DELISTED
Coresite Realty Corporation
COR
$2.31M 0.63%
33,000
+5,000
+18% +$314K
STJ
54
DELISTED
St Jude Medical
STJ
$2.26M 0.61%
41,140
+8,130
+25% +$443K
JNJ icon
55
Johnson & Johnson
JNJ
$621B
$2.26M 0.61%
+20,900
New +$2.16M
NFLX icon
56
Netflix
NFLX
$309B
$2.2M 0.6%
214,900
-182,400
-46% -$1.79M
ABMD
57
DELISTED
Abiomed Inc
ABMD
$2.18M 0.59%
23,000
+2,500
+12% +$211K
LFUS icon
58
Littelfuse
LFUS
$11.7B
$2.09M 0.57%
+17,000
New +$1.87M
FSLR icon
59
First Solar
FSLR
$25.4B
$2.09M 0.57%
+30,500
New +$2.04M
CORV
60
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$2.07M 0.56%
505,420
-203,468
-29% -$1.09M
MXL icon
61
MaxLinear
MXL
$6.12B
$2.04M 0.55%
110,000
-35,000
-24% -$555K
TSRO
62
DELISTED
TESARO, Inc.
TSRO
$2.02M 0.55%
+45,860
New +$1.84M
PBH icon
63
Prestige Consumer Healthcare
PBH
$2.51B
$1.98M 0.54%
37,000
-26,000
-41% -$1.28M
TVTX icon
64
Travere Therapeutics
TVTX
$5.84B
$1.95M 0.53%
142,864
-241,896
-63% -$3.67M
OIG
65
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$1.92M 0.52%
5,950
+102
+2% +$32.1K
HII icon
66
Huntington Ingalls Industries
HII
$12.5B
$1.86M 0.5%
+13,560
New +$1.76M
UTEK
67
DELISTED
Ultratech Inc.
UTEK
$1.84M 0.5%
+84,400
New +$1.67M
HRTX icon
68
Heron Therapeutics
HRTX
$95.5M
$1.83M 0.5%
96,570
-9,510
-9% -$188K
EXLS icon
69
EXL Service
EXLS
$5.11B
$1.81M 0.49%
+175,000
New +$1.61M
LITE icon
70
Lumentum
LITE
$64.3B
$1.79M 0.49%
+66,500
New +$1.54M
MPAA icon
71
Motorcar Parts of America
MPAA
$263M
$1.78M 0.48%
47,000
+13,000
+38% +$443K
VSTO
72
DELISTED
Vista Outdoor Inc.
VSTO
$1.76M 0.48%
+34,000
New +$1.64M
OLLI icon
73
Ollie's Bargain Outlet
OLLI
$4.74B
$1.76M 0.48%
+75,000
New +$1.54M
ULTA icon
74
Ulta Beauty
ULTA
$23.2B
$1.76M 0.48%
9,070
+7,570
+505% +$1.32M
MTSI icon
75
MACOM Technology Solutions
MTSI
$20.1B
$1.75M 0.47%
+40,000
New +$1.57M

Similar funds

Turner Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Turner Investments held 302 positions worth $369M, down 24% from $483M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Turner Investments withdrew a net $97.1M in Q1 2016, closing 95 positions and reducing 69 holdings. Its most notable exit was Aptiv, an estimated $5.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Edwards Lifesciences worth $4.87M.

  • Turner Investments's largest Q1 2016 buy was Edwards Lifesciences: 165,450 shares worth $4.87M.
  • Turner Investments added most to SolarEdge in Q1 2016, an estimated $4.14M increase.
  • Turner Investments's biggest Q1 2016 reduction was Eli Lilly, cutting an estimated $6.93M.
  • Turner Investments fully exited Aptiv in Q1 2016, selling an estimated $5.73M.
  • Turner Investments's ten largest holdings make up 18% of its $369M portfolio in Q1 2016.
  • Turner Investments opened 88 new positions and closed 95 in Q1 2016.
  • Turner Investments's portfolio value fell 24% quarter-over-quarter to $369M.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.